DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okita, J. R.
Right arrow Articles by Okita, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okita, J. R.
Right arrow Articles by Okita, R. T.

0090-9556/97/2508-1008-1012$02.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics
Vol. 25, No. 8

Improved Separation and Immunodetection of Rat Cytochrome P450 4A Forms in Liver and Kidney

Janice Rice Okita, Steven B. Johnson, Pamela J. Castle, Sheryl C. Dezellem, and Richard T. Okita

Department of Pharmaceutical Sciences and the Pharmacology and Toxicology Graduate Program, College of Pharmacy, Washington State University

In the study of tissues that contain several forms of one cytochrome P450 subfamily, it is useful to develop immunoblotting techniques so that the various individual members of the family can be distinguished. This paper describes improvements in the immunoblotting technique to distinguish members of the rat cytochrome P450 4A subfamily, 4A1, 4A2, and 4A3, as they are present in Sprague-Dawley rat liver microsomes. This procedure was used to investigate differences in the cytochrome P450 4A forms observed under various conditions such as: untreated versus peroxisome proliferator treated rats, Sprague-Dawley versus Fischer 344 male versus female rats, and liver versus kidney microsomes. In liver microsomes of male Sprague-Dawley rats, forms 4A1, 4A2, and 4A3 were induced by the peroxisome proliferators, clofibrate, di-(2-ethylhexyl) phthalate, dehydroepiandrosterone, aspirin, and ibuprofen. Expression of the 4A forms shows strain specificity. A comparison of the cytochrome P450 4A forms in male Sprague-Dawley and Fischer 344 rats treated with peroxisome proliferators demonstrated that three distinct protein bands are visible on immunoblots of liver microsomes of Sprague-Dawley rats, whereas only two distinct protein bands are detectable in liver microsomes of Fischer 344 rats. The two protein bands in liver microsomes of male Fischer 344 rats migrate in positions corresponding to the 4A2 and 4A3 bands in male Sprague-Dawley rats. There did not appear to be a protein band corresponding to the 4A1 band of Sprague-Dawley rats. Expression of the 4A forms also shows gender specificity. In liver microsomes of female Sprague-Dawley rats, expression of the P450 4A2 form was not observed after treatment with a peroxisome proliferator. Expression of the 4A forms also shows tissue specificity. In kidney, 4A2 is the major protein band in male Sprague-Dawley rats with minor amounts of the 4A3 protein, whereas two prominent protein bands (4A2 and 4A3) are seen in male Fischer 344 rats.


Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. M. Poloyac, M. A. Tortorici, D. I. Przychodzin, R. B. Reynolds, W. Xie, R. F. Frye, and M. A. Zemaitis
THE EFFECT OF ISONIAZID ON CYP2E1- AND CYP4A-MEDIATED HYDROXYLATION OF ARACHIDONIC ACID IN THE RAT LIVER AND KIDNEY
Drug Metab. Dispos., July 1, 2004; 32(7): 727 - 733.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Li-Masters and E. T. Morgan
Effects of Bacterial Lipopolysaccharide on Phenobarbital-Induced CYP2B Expression in Mice
Drug Metab. Dispos., March 1, 2001; 29(3): 252 - 257.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Nguyen, M.-H. Wang, K. M. Reddy, J. R. Falck, and M. L. Schwartzman
Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1691 - R1700.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
B. S. Cummings, R. C. Zangar, R. F. Novak, and L. H. Lash
Cellular Distribution of Cytochromes P-450 in the Rat Kidney
Drug Metab. Dispos., April 1, 1999; 27(4): 542 - 548.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
M.-H. Wang, H. Guan, X. Nguyen, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman
Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys
Am J Physiol Renal Physiol, February 1, 1999; 276(2): F246 - F253.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Kroetz, P. Yook, P. Costet, P. Bianchi, and T. Pineau
Peroxisome Proliferator-activated Receptor alpha  Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes
J. Biol. Chem., November 20, 1998; 273(47): 31581 - 31589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Su, K. M. Kaushal, and D. L. Kroetz
Inhibition of renal arachidonic acid omega -hydroxylase activity with ABT reduces blood pressure in the SHR
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R426 - R438.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.